4//SEC Filing
Elliott Michael James 4
Accession 0001764013-21-000038
CIK 0001764013other
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 8:43 AM ET
Size
7.4 KB
Accession
0001764013-21-000038
Insider Transaction Report
Form 4
Immunovant, Inc.IMVT
Elliott Michael James
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2021-03-19+342,300→ 342,300 totalExercise: $17.00Exp: 2031-03-19→ Common Stock (342,300 underlying) - Award
Common Stock
2021-03-19+97,600→ 97,600 total
Footnotes (3)
- [F1]Represents the number of shares underlying restricted stock units awards ("RSUs").
- [F2]The RSUs vest over four years, with 25% of the RSUs vesting on March 19, 2022 and the remainder of the RSUs vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.
- [F3]Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on March 19, 2022 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.
Documents
Issuer
Immunovant, Inc.
CIK 0001764013
Entity typeother
Related Parties
1- filerCIK 0001822515
Filing Metadata
- Form type
- 4
- Filed
- Mar 22, 8:00 PM ET
- Accepted
- Mar 23, 8:43 AM ET
- Size
- 7.4 KB